Phase 3 Overdose Clinical Trials

4 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–4 of 4 trials

Recruiting

Phase 2Phase 3

Naltrexone for Overdose Prevention

Overdose Accidental

University of California, San Francisco100 enrolled1 locationNCT06633900

Recruiting

Phase 3

Antenatal Magnesium Sulphate in High-Risk Preterm Patients

Cerebral PalsyMagnesium Sulfate Overdose

Cairo University138 enrolled1 locationNCT07524972

Recruiting

Phase 3

The NACSTOP 2 trial: Investigation of the early cessation of N-acetylcysteine in patients following paracetamol overdose.

paracetamol overdose

Monash Health200 enrolled6 locationsACTRN12619001549112

Recruiting

Phase 3

Double NAC trial: Investigation of increased N-acetylcysteine dosing in patients treated for paracetamol overdose.

paracetamol overdose

Monash Health230 enrolled6 locationsACTRN12619001548123